Demant A/S

Common Name
Demant
Country
Denmark
Sector
Healthcare
Industry
Medical Devices
Employees
22,057
Ticker
DEMANT
Exchange
NASDAQ COPENHAGEN A/S
Description
Demant A/S is a global leader in the hearing healthcare industry, offering a comprehensive range of products and solutions to support individuals with hearing loss. Primarily known for its advanced he...

Financial Statements of Demant

Below are the financial statements of Demant, including the income statement and balance sheet for the company's latest fiscal year. All figures are accurate, verifiable, and fully traceable to the original annual filing where disclosed.

All figures in millions of DKK20242023
Revenue
22,419a
21,601a
Production costs
-5,329a
-5,281a
Gross profit
17,090a
16,320a
R&D costs
-1,394a
-1,226a
Distribution costs
-10,246a
-9,554a
Administrative expenses
-1,145a
-1,102a
Share of profit after tax, associates
99a
68a
Operating profit (EBIT) before special items
4,404a
4,506a
Special items
124a
0a
Operating profit (EBIT)
4,528a
4,506a
Financial income
113a
95a
Financial expenses
-925a
-856a
Profit before tax
3,716a
3,745a
Tax on profit for the year
-824a
-922a
Profit after tax - continuing operations
2,892a
2,823a
Profit after tax - discontinued operations
-504a
-1,025a
Profit for the year
2,388a
1,798a
Profit for the year attributable to:
Demant A/S' shareholders
2,387a
1,795a
Non-controlling interests
1a
3a

Verified Sources Behind Demant’s Financial Fundamentals Data

Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform. Explore Demant’s data sources below and access millions more through our Disclosure Search.

a. Demant's Annual Report 2024
Trace every data point back to Demant’s disclosures

Sign up for Tracenable and access millions of corporate disclosures, including annual reports and sustainability filings from global companies, completely free of charge.

Real-Time & Standardized Financials

Access Standardized Financial Statements within Minutes of Disclosure

At Tracenable, we're exploring the launch of real-time standardized financial datafeeds and APIs covering global equities. Unlike limited and inconsistent XBRL parsing, our approach aims to deliver clean, comparable, and fully traceable data seconds after publication.

Could this solution support your investment or analytical workflows?